NYSE:BSXMedical Equipment
How New Urology Clearance and Galway R&D Push Will Impact Boston Scientific (BSX) Investors
In recent days, Boston Scientific has secured FDA 510(k) clearance for its Asurys Fluid Management System and announced a €75.00 million R&D expansion in Galway, Ireland, ahead of its April 22, 2026 earnings release.
Together, the new urology technology clearance and cardiovascular-focused R&D investment highlight how Boston Scientific is reinforcing its pipeline across two core therapy areas.
We’ll now examine how the FDA clearance of Asurys and the expanded Galway R&D hub could influence...